Deep phenotyping and spatial interrogation of the NSCLC tumor microenvironment using the fully validated Next Generation MultiOmyx™ Platform
SITC 2024
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients